Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-13

Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of the inactivated varicella-zoster vaccine for preventing herpes zoster and related complications in adults wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inactivated Varicella-zoster Vaccine (VZV)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Herpes Zoster | Phase 3 | Status: COMPLETED | Results posted: 2018-04-13